Liver volume in the cirrhotic patient: does size matter?

Area of Science:

• Hepatology
• Transplant Medicine
• Prognostic Biomarkers

Background:

• Cirrhosis is known to decrease liver volume (LV).
• The prognostic significance of LV in cirrhosis patients remains unclear.
• This study investigates LV as a predictor of survival in cirrhosis.

Purpose of the Study:

• To determine if estimated liver volume (LV) is a significant prognostic indicator in patients with cirrhosis.
• To assess the predictive value of LV, adjusted for body size (LV/IBW), for patient survival.
• To evaluate LV's independence from the Model for End-Stage Liver Disease (MELD) score.

Main Methods:

• Retrospective analysis of 323 patients evaluated for liver transplant (2001-2006).
• Liver volume per ideal body weight (LV/IBW) was calculated and stratified.
• Survival analyses were performed, categorizing patients by disease type (hepatocellular, cholestatic, miscellaneous).

Main Results:

• A lower LV/IBW ratio was significantly associated with an increased risk of transplant or death (p=0.022).
• This association was particularly robust in patients with hepatocellular disease (p=0.002).
• Multivariate analysis indicated LV/IBW trended towards predicting transplant/death independently of MELD score (p=0.053).

Conclusions:

• Liver volume (LV) holds significant predictive value for patients with cirrhosis, particularly those with hepatocellular disease.
• LV appears to provide prognostic information not captured by the MELD score alone.
• LV may serve as a valuable adjunct to the MELD score for prognostication in hepatocellular disease.